Papachristou S - Search Results

1

Advanced Glycation End Products and Well-Being in Male Subjects with Type 2 Diabetes Mellitus.

Papachristou S, Kazakos K, Moschos I, Papazoglou D, Papanas N. Papachristou S, et al. Exp Clin Endocrinol Diabetes. 2024 Jan;132(1):47-48. doi: 10.1055/a-2197-2694. Epub 2023 Dec 22. Exp Clin Endocrinol Diabetes. 2024. PMID: 38134916 No abstract available.

2

Good Practice Statements for the treatment of nicotine dependence.

Solimini R, Ruokolainen O, Cselko Z, Koprivnikar H, Spizzichino L, Papachristou S, González-Marrón A, Nunes E, Carnicer-Pont D, Fernandez E, López AM, Demosthenous E, Kilibarda B, Gallus S, Gómez-Chacón C, Keć I, Valentic M, Ollila H. Solimini R, et al. Among authors: papachristou s. Tob Prev Cessat. 2023 Jul 12;9:24. doi: 10.18332/tpc/167964. eCollection 2023. Tob Prev Cessat. 2023. PMID: 37448706 Free PMC article. No abstract available.

3

Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus.

Papachristou S, Pafili K, Trypsianis G, Papazoglou D, Vadikolias Κ, Papanas N. Papachristou S, et al. J Diabetes Complications. 2022 Dec;36(12):108356. doi: 10.1016/j.jdiacomp.2022.108356. Epub 2022 Nov 8. J Diabetes Complications. 2022. PMID: 36395605

4

Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?

Papachristou S, Rizzo M, Papanas N. Papachristou S, et al. Exp Clin Endocrinol Diabetes. 2022 Oct;130(10):636-637. doi: 10.1055/a-1903-1752. Epub 2022 Aug 17. Exp Clin Endocrinol Diabetes. 2022. PMID: 35977693

5

Correlation Between Skin Advanced Glycation End Products and Cardiac Autonomic Neuropathy Among Subjects with Type 2 Diabetes Mellitus.

Papachristou S, Pafili K, Trypsianis G, Papazoglou D, Vadikolias Κ, Papanas N. Papachristou S, et al. Exp Clin Endocrinol Diabetes. 2022 Dec;130(12):767-772. doi: 10.1055/a-1831-0991. Epub 2022 Apr 21. Exp Clin Endocrinol Diabetes. 2022. PMID: 35451045

6

Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?

Papachristou S, Popovic DS, Papanas N. Papachristou S, et al. Adv Ther. 2022 Jun;39(6):2283-2286. doi: 10.1007/s12325-022-02125-1. Epub 2022 Mar 28. Adv Ther. 2022. PMID: 35344184

7

Diabetes Mellitus and Bell's Palsy.

Stamatiou I, Papachristou S, Papanas N. Stamatiou I, et al. Among authors: papachristou s. Curr Diabetes Rev. 2023;19(1):e080322201913. doi: 10.2174/1573399818666220308161023. Curr Diabetes Rev. 2023. PMID: 35260056

8

Ezetimibe and Insulin Resistance.

Popovic DS, Papachristou S, Stokic E, Papanas N. Popovic DS, et al. Among authors: papachristou s. Curr Vasc Pharmacol. 2022;20(4):315-317. doi: 10.2174/1570161120666220301140528. Curr Vasc Pharmacol. 2022. PMID: 35232351 No abstract available.

9

Skin Advanced Glycation End Products among Subjects with Type 2 Diabetes Mellitus with or without Distal Sensorimotor Polyneuropathy.

Papachristou S, Pafili K, Trypsianis G, Papazoglou D, Vadikolias K, Papanas N. Papachristou S, et al. J Diabetes Res. 2021 Nov 28;2021:6045677. doi: 10.1155/2021/6045677. eCollection 2021. J Diabetes Res. 2021. PMID: 34877359 Free PMC article.

10

The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?

Papachristou S, Popovic DS, Papanas N. Papachristou S, et al. Diabetes Metab Res Rev. 2021 Nov;37(8):e3503. doi: 10.1002/dmrr.3503. Epub 2021 Oct 15. Diabetes Metab Res Rev. 2021. PMID: 34626443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page